Press Releases, Conferences and Posters

Press Releases for our Investigational System, Clinical Trials and Technology

June 13, 2022

Lumicell Appoints Brent Palmisano Chief Commercial Officer, Builds Commercial Team


March 9, 2022

Clinical Data on Lumicell’s Direct Visualization System to Be Presented at International Conference on Surgical Cancer Care


September 30, 2021

Lumicell Completes Enrollment in the INSITE Pivotal Trial for Intraoperative Breast Cancer Detection & Removal


November 17, 2020

Lumicell Granted Fast Track Designation Approval by the FDA for Breast Cancer Treatment


September 29, 2020

Lumicell Announces Initiation of NIH/NCI Academic-Industry Study of its LUM Imaging System


September 16, 2020

Howard Hechler Joins Lumicell as Senior Vice President of Strategy & Business Development




Events & Presentations

TARGIT Collaborative Group 3rd Annual Conference
September 16-17 in Orlando, FL

The TCG Annual Conference gathers the finest radiation oncologists, cancer surgeons, physicists, and other cancer experts that share a common commitment to improving cancer patient care through education, patient advocacy, mentorship, and collaborative research.



Targeted Medical Education (TME) “Take the Lead in Breast Cancer Care” Symposium Roundtable
October 21-22, 2022, in Las Vegas, NV

TME and Breast Care Network are a group of community-leading breast cancer doctors whose goal is to cut through the avalanche of "new developments" in breast cancer, eliminating the spurious, and implementing genuine advances. This meeting engages breast care physician attendees with the opportunity to learn about new technology, coding and reimbursement, risk assessment, surgical procedures, genetic and genomic testing, advanced treatment options, survivorship issues and innovations in breast cancer care.



SSO Fellow’s Workshop
November 28-30, 2022 at the Methodist Institute of Technology, Innovation & Education (MITIE) Center in Houston, TX

An annual educational program cosponsored by the Americas Hepato-Pancreato-Biliary Association (AHPBA) and the American Society of Breast Surgeons (ASBrS). Fellows Institute promotes professional collegial relationships with peers and medical society members. It reinforces that learning is a life-long professional responsibility to be maintained through Continuous Certification and continuing education.



San Antonio Breast Cancer Symposium
December 6-10, 2022 in San Antonio, TX

SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers.



SSO 2023 International Conference on Surgical Cancer Care
March 22-25, 2023, in Boston, MA

The Society of Surgical Oncology is a dynamic global community of cancer surgeons shaping advancements in the profession to deliver the highest quality surgical care for cancer patients. SSO promotes leading-edge research, quality standards and knowledge exchange, connecting cancer surgeons worldwide to continuously improve cancer outcomes.



The American Society of Breast Surgeons (ASBrS) 24th Annual Meeting
April 26-30, 2023, in Boston, MA

The American Society of Breast Surgeons is the primary leadership organization for general surgeons who treat patients with breast disease and is committed to continually improving the practice of breast surgery by serving as an advocate for surgeons who seek excellence in the care of breast patients. This year’s annual meeting circulates around themes related to surgical innovation, and features presentations and discussions on cutting-edge topics.






Expansion into Multiple Institutions for Training in the use of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects with Breast Cancer | View Poster

Feasibility, safety and initial efficacy of cathepsin-activatable fluorescent probes for molecular detection of colorectal and esophageal neoplasia | View Poster

Feasibility, safety and efficacy of cathepsin-activatable fluorescent probes for molecular detection of pancreatic adenocarcinoma | View Poster

Expansion into multiple institutions for training in the use of the LUM Imaging System for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer | View Poster

Use of cathepsin-activatable fluorescent agent to rapidly distinguish tumors versus normal tissue in multiple tumor types | View Poster

Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins using the LUM Imaging System: Results of a feasibility study | View Poster

Feasibility of the LUM Imaging System for real-time, intraoperative detection of residual breast cancer in lumpectomy cavity margins | View Poster